Winssinger Frederic J's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Jul 30, 2021
- Accession no.
- 0001179110-21-007761
- Filed
- Jul 30, 2021
- Trade date
- Jul 28-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $91.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Winssinger Frederic JCIK 0001673356 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Common Stock | MOption exerciseDisposed | −312 | $0.00 | $0 | 936 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
Referenced by the price of 1 transaction in Table I.
- F3
Weighted average price $99.08. Price range in multiple transactions was $98.93 to $99.11 inclusively.
Referenced by the price of 1 transaction in Table I.